Absci Corp. (ABSI)
8.84
-0.71
(-7.43%)
USD |
NASDAQ |
Aug 24, 16:00
8.84
0.00 (0.00%)
After-Hours: 20:00
Absci Price to Book Value : 6.162 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 6.162 |
| August 21, 2026 | 6.656 |
| August 20, 2026 | 6.468 |
| August 19, 2026 | 6.963 |
| August 18, 2026 | 6.169 |
| August 17, 2026 | 6.440 |
| August 14, 2026 | 6.399 |
| August 13, 2026 | 6.594 |
| August 12, 2026 | 6.622 |
| August 11, 2026 | 6.559 |
| August 10, 2026 | 6.280 |
| August 07, 2026 | 6.224 |
| August 06, 2026 | 5.785 |
| August 05, 2026 | 5.855 |
| August 04, 2026 | 5.911 |
| August 03, 2026 | 5.527 |
| July 31, 2026 | 5.423 |
| July 30, 2026 | 5.325 |
| July 29, 2026 | 4.809 |
| July 28, 2026 | 4.970 |
| July 27, 2026 | 5.270 |
| July 24, 2026 | 5.270 |
| July 23, 2026 | 5.625 |
| July 22, 2026 | 5.743 |
| July 21, 2026 | 5.799 |
| Date | Value |
|---|---|
| July 20, 2026 | 5.688 |
| July 17, 2026 | 5.782 |
| July 16, 2026 | 5.736 |
| July 15, 2026 | 6.803 |
| July 14, 2026 | 7.130 |
| July 13, 2026 | 7.117 |
| July 10, 2026 | 7.388 |
| July 09, 2026 | 7.995 |
| July 08, 2026 | 7.737 |
| July 07, 2026 | 7.897 |
| July 06, 2026 | 8.044 |
| July 02, 2026 | 8.099 |
| July 01, 2026 | 7.744 |
| June 30, 2026 | 8.078 |
| June 29, 2026 | 10.25 |
| June 26, 2026 | 9.838 |
| June 25, 2026 | 9.223 |
| June 24, 2026 | 9.101 |
| June 23, 2026 | 6.694 |
| June 22, 2026 | 7.588 |
| June 18, 2026 | 6.694 |
| June 17, 2026 | 6.486 |
| June 16, 2026 | 6.324 |
| June 15, 2026 | 6.567 |
| June 12, 2026 | 6.143 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Twist Bioscience Corp. | 19.80 |
| Prime Medicine, Inc. | 14.76 |
| Tenax Therapeutics, Inc. | 0.5204 |
| Exicure, Inc. | 7.502 |
| Recursion Pharmaceuticals, Inc. | 1.897 |
Price to Book Value Related Metrics
| PS Ratio | 856.27 |
| Price | 8.84 |
| Earnings Yield | -9.05% |
| Market Cap | 1.517B |